Literature DB >> 29125117

Research Advances in the Neuroinflammation in Alzheimer's Disease.

Wen-Pei Ma1, Xuan Zhang2, Qiong Wu3.   

Abstract

Alzheimer's disease(AD) is a chronic degenerative disease of the nervous system,and the pathological change of AD is the formation of senile plaques containing amyloid β(Aβ) and the neurofibrillary tangles. AD patients and animal models exhibit the over activation of microglia(MG) and astrocytes,causing neuroinflammation,leading to neuron death. Inhibition of MG activity can alleviate Aβ plaques. A growing number of studies have found that neuroinflammation is involved in the development and progression of AD. This article reviews the role of neuroinflammation induced by MG,astrocytes,T lymphocyte,and monocyte-derived macrophages in the mechanism of AD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29125117     DOI: 10.3881/j.issn.1000-503X.2017.05.019

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  2 in total

Review 1.  Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease.

Authors:  Hong Guo; Hui Cao; Xiaowei Cui; Wenxiu Zheng; Shanshan Wang; Jiyang Yu; Zhi Chen
Journal:  Molecules       Date:  2019-05-06       Impact factor: 4.411

2.  Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk.

Authors:  Josue D Gonzalez Murcia; Allen Weinert; Claudia M Tellez Freitas; Daniel K Arens; Meganne N Ferrel; Julianne H Grose; Perry G Ridge; Eric Wilson; John S K Kauwe; K Scott Weber
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.